From: Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas
Variables | Number of cases(%) |
---|---|
Number of patients | 78(100%) |
Age(y) | |
≤ 60 | 44(56.4%) |
> 60 | 34(43.6%) |
Gender | |
Male | 55(70.5%) |
Female | 23(28.5%) |
Tumor localisation | |
Proximal | 33(42.3%) |
Distal | 45(57.7%) |
Histologic grade | |
Undifferentiated(G4) | 13(16.7%) |
Poorly differentiated(G3) | 27(34.6%) |
Moderately differentiated(G2) | 29(37.2%) |
Well differentiated(G1) | 9(11.5%) |
Tumor stage | |
Stage I + II | 35(44.9%) |
Stage III + IV | 43(55.1%) |
Primary tumor | |
T1-2 | 12(15.4%) |
T3-4 | 66(84.6%) |
Regional lymph nodes | |
N0 | 34(43.6%) |
N1-3 | 44(56.4%) |